Bank of Montreal’s Akcea Therapeutics Inc AKCA Stock Holding History

Bank of Montreal’s Portfolio AKCA Stock Details AKCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-6,510	Closed	-$118K	–	5245
2020 Q3	$118K	Buy	6,510 +5,190	+393%	+$73.6K	﹤0.01%	2995
2020 Q2	$18K	Buy	+1,320	New	+$20.4K	﹤0.01%	3908
2020 Q1	–	Sell	-1,565	Closed	-$27K	–	5031
2019 Q4	$27K	Sell	1,565 -1,226	-44%	-$22.8K	﹤0.01%	4154
2019 Q3	$43K	Sell	2,791 -17,943	-87%	-$382K	﹤0.01%	3711
2019 Q2	$486K	Buy	20,734 +1,034	+5%	+$25.5K	﹤0.01%	2442
2019 Q1	$558K	Buy	19,700 +19,523	+11,030%	+$569K	﹤0.01%	2246
2018 Q4	$5K	Buy	177 +89	+101%	+$2.5K	﹤0.01%	4128
2018 Q3	$3K	Sell	88 -2	-2%	-$61	﹤0.01%	4293
2018 Q2	$2K	Buy	+90	New	+$2.15K	﹤0.01%	4454

Bank of Montreal's AKCA Position: Q4 2020 in Review

Bank of Montreal sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 6,510 shares — an estimated $118K sold.

Bank of Montreal first reported a position in AKCA in Q2 2018 and held it in 9 quarters. The position peaked at $558K in Q1 2019. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

Bank of Montreal reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
Bank of Montreal sold 6,510 Akcea Therapeutics Inc shares in Q4 2020, an estimated $118K.
Bank of Montreal first reported a position in Akcea Therapeutics Inc in Q2 2018 and held it in 9 quarters.
Bank of Montreal's Akcea Therapeutics Inc position peaked at $558K in Q1 2019.
0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Bank of Montreal's 13F filing for Q4 2020, filed 12 Feb 2021.